Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychopharmacology of Biogenic Amines in Depression
NCT00320632Phase 4Completed
- Sponsor
- Harvard Medical School
- Start
- Aug 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desipramine in major depressive disorder (MDD), sponsored by Harvard Medical School. Started Aug 1990; status: completed.
02
Drugs
desipramine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00320632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00320632.